儿童接触亲密伴侣暴力的ICD-10代码
Mohammed Sayeem1, May Shum2, Caitlin Ryus3
1Yale New Haven Children's Hospital, New Haven, CT.
Academic pediatrics
|February 6, 2026
概括
对于亲密伴侣暴力 (IPV) 暴露的儿科医生访问通常使用非特定的ICD-10代码. 在儿科急诊部 (PED) 和儿童倡导中心 (CAC) 之间,文档不同,限制了IPV的系统识别.
科学领域:
- 儿科医疗保健服务 儿科医疗保健服务
- 公共卫生 公共卫生
- 医学编码 医学编码
背景情况:
- 亲密伴侣暴力 (IPV) 显著影响儿童的福祉.
- 在儿科环境中准确识别IPV暴露对于干预至关重要.
- 当前的诊断编码实践可能无法有效地捕捉所有与IPV相关的儿科接触.
研究的目的:
- 为了确定常见的国际疾病分类,第十次修订,临床修改 (ICD-10-CM) 代码用于与护理人员IPV相关的儿科访问.
- 为了比较使用与IPV相关的诊断代码在儿科急诊部 (PED) 和儿童倡导中心 (CAC) 的评估之间.
- 评估ICD-10代码在儿科卫生保健机构识别IPV的特异性和有效性.
主要方法:
- 从2019年7月到2022年6月,针对IPV相关护理的儿科接触的二次分析.
- 包括在儿童保护服务转介后访问PED或CAC的情况.
- 描述性的ICD-10-CM代码的总结和基于评估网站的代码使用的检查.
主要成果:
- 在92次儿科接触中,发现了174个不同的ICD-10代码.
- 85%的遭遇与IPV相关的诊断代码,疑似滥用或社会问题有关 (例如,Z63,T74,T76,Z60).
- 儿童倡导中心 (CAC) 遇到的与IPV相关的代码比儿科急诊室 (PED) 评估 (98%对66%,p <0.01) 的可能性要高得多.
结论:
- ICD-10代码组Z63,T74,T76和Z60经常使用,但对IPV缺乏特异性.
- 在CAC和PED设置之间代码使用的变化可能表明提供商的不确定性或安全问题.
- 仅ICD-10代码就不足以对儿科IPV暴露进行可靠的识别,原因是特异性有限和文档不一致.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:39lncRNA - Long Non-coding RNAs
3.7K
3.7K
01:29Nursing Code of Ethics
4.6K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.6K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
317
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
237
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237